Intravenous immunoglobulin as rescue therapy for BK virus nephropathy

Pediatric Transplantation

Volumn 13, Issue 1, 2009, Pages 123-129

  Sharma, Ajay P ^a   Moussa, Madeleine ^a   Casier, Shelley ^a   Rehman, Faisal ^a   Filler, Guido ^a   Grimmer, Joanne ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

BK virus; Cidofovir; Immunoglobulin; Kidney transplantation; Pediatric; Polyoma

Indexed keywords

CIDOFOVIR; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; GANCICLOVIR; IMMUNOGLOBULIN; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ANAMNESIS; ARTICLE; BK VIRUS; CASE REPORT; CHILD; DRUG WITHDRAWAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; LABORATORY TEST; LOW DRUG DOSE; MALE; PRESCHOOL CHILD; TREATMENT RESPONSE; VIREMIA;

ANTIVIRAL AGENTS; BK VIRUS; CHILD, PRESCHOOL; CREATININE; CYTOSINE; GANCICLOVIR; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; PHOSPHONIC ACIDS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 58149301555     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00958.x     Document Type: Article

References (37)

1. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003 : 75 : 1266 1270.
2. Alexander RT, Langlois V, Tellier R, Robinson L, Hebert D. The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: A single-center retrospective analysis. Pediatr Transplant 2006 : 10 : 586 592.
3. Herman J, Van Ranst M, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R. Polyomavirus infection in pediatric renal transplant recipients: Evaluation using a quantitative real-time PCR technique. Pediatr Transplant 2004 : 8 : 485 492.
4. Hymes LC, Warshaw BL. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006 : 10 : 920 922.
5. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2007 : 2 : 1037 1042.
6. Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007 : 22 : 1243 1250.
7. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004 : 4 : 2109 2117.
8. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007 : 7 : 2727 2735.
9. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997 : 41 : 587 593.
10. De Luca A, Giancola ML, Ammassari A, et al. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 2000 : 14 : F117 F121.
11. Lalezari JP, Drew WL, Glutzer E, et al. (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine (cidofovir): Results of a phase I/II studyof a novel antiviral nucleotide analogue. J Infect Dis 1995 : 171 : 788 796.
12. Cundy KC, Petty BG, Flaherty J, et al. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1995 : 39 : 1247 1252.
13. Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003 : 75 : 105 112.
14. Araya CE, Lew JF, Fennell RS III., Neiberger RE, Dharnidharka VR. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant 2006 : 10 : 32 37.
15. Gold R, Stangel M, Dalakas MC. Drug insight: The use of intravenous immunoglobulin in neurology - therapeutic considerations and practical issues. Nat Clin Pract Neurol 2007 : 3 : 36 44.
16. Kumar A, Teuber SS, Gershwin ME. Intravenous immunoglobulin: Striving for appropriate use. Int Arch Allergy Immunol 2006 : 140 : 185 198.
17. Al-Uzri AY, Seltz B, Yorgin PD, Spier CM, Andreoni K. Successful renal transplant outcome after intravenous gamma-globulin treatment of a highly sensitized pediatric recipient. Pediatr Transplant 2002 : 6 : 161 165.
18. Anglicheau D, Loupy A, Suberbielle C, et al. Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: A pilot study. Am J Transplant 2007 : 7 : 1185 1192.
19. Casadei DH, del CRM, Opelz G, et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001 : 71 : 53 58.
20. Luke PP, Scantlebury VP, Jordan ML, et al. Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 2001 : 72 : 419 422.
21. Jordan SC, Vo AA, Peng A, Toyoda M, Tyan D. Intravenous gammaglobulin (IVIG): A novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am J Transplant 2006 : 6 : 459 466.
22. Azzi A, Fanci R, Ciappi S, Zakrzewska K, Bosi A. Human parvovirus B19 infection in bone marrow transplantation patients. Am J Hematol 1993 : 44 : 207 209.
23. Sechet A, Bridoux F, Bauwens M, Ayache RA, Belmouaz S, Touchard G. Prevention of cytomegalovirus infection and disease in high-risk renal transplant recipients with polyvalent intravenous immunoglobulins. Transplant Proc 2002 : 34 : 812 813.
24. Mofenson LM, Moye J Jr., Bethel J, et al. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 × 10 (9)/L or more. Effect on viral, opportunistic, and bacterial infections. JAMA 1992 : 268 : 483 488.
25. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 2006 : 81 : 117 120.
26. Johnson G, Nelson S, Petric M, Tellier R. Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol 2000 : 38 : 3274 3279.
27. Ryschkewitsch C, Jensen P, Hou J, Fahle G, Fischer S, Major EO. Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. J Virol Methods 2004 : 121 : 217 221.
28. Hammer MH, Brestrich G, Andree H, et al. HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am J Transplant 2006 : 6 : 625 631.
29. Ginevri F, Pastorino N, de Santis R, et al. Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 2003 : 42 : 821 825.
30. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006 : 81 : 704 710.
31. Muller A, Beck B, Theilemann K, et al. Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients. Pediatr Infect Dis J 2005 : 24 : 778 781.
32. Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003 : 3 : 186 191.
33. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004 : 4 : 2082 2092.
34. Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004 : 42 : 1176 1180.
35. Puliyanda D, Radha RK, Amet N, et al. IVIG containing antibodies reacting with polyoma BK virus may represent a therapeutic option for BK nephropathy. Am J Transplant 2003 : 3 (Suppl. 5 393.
36. Mannon RB, Hoffmann SC, Kampen RL, et al. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 2005 : 5 : 2883 2893.
37. Green M. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 2001 : 1 : 103 108.